Clinical Trial Results TV
November 8, 2011: Dr. Clemens von Birgelen and Dr. C. Michael Gibson discuss: TWENTE
Dr. Clemens von Birgelen and Dr. C. Michael Gibson discuss: TWENTE: A Prospective,
Randomized Trial of Zotarolimus-Eluting Stents and Everolimus-Eluting Stents in Patients
with Coronary Artery Disease

Dr. von Birgelen is a consultant to and has received speakers honoraria and/or travel
expenses from:
Abbott Vascular, Medtronic, and Boston Scientific

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
12-17-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted